Yarrow Bioscience YARW
NASDAQ YARW
$19.95 -0.26 (-1.29%)
As of: Oct 21, 2026 · 1:10 PM EDT

Yarrow Bioscience (YARW) Operating Leases (2019 - 2024)

Updated

Yarrow Bioscience (YARW) reported Operating Leases of $25,000 for Q2 2024, down 60.3% from the prior quarter.

Analysis

Yarrow Bioscience (YARW) Operating Leases (2019 - 2024) Analysis & Trends

At the end of FY2023, Yarrow Bioscience posted Operating Leases of $99,000.

  • Operating Leases has a four-year compound annual growth rate of -37.6% (FY2019 to FY2023).
  • By year, Operating Leases came in at $853,000 in FY2020 (+30.6%) and $653,000 in FY2019.
  • The Q2 2024 figure ranks as the lowest quarterly Operating Leases in data going back to Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.69 Bn 1,103.27 Bn 19.71 Bn
2 Johnson & Johnson 616.29 Bn 534.82 Bn 17.26 Bn
3 AbbVie 500.86 Bn 473.97 Bn 12.70 Bn
4 Merck 366.77 Bn 321.15 Bn 12.21 Bn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn
7 Amgen 235.52 Bn 190.92 Bn 7.24 Bn
8 Gilead Sciences 190.49 Bn 164.69 Bn 6.22 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn
10 Yarrow Bioscience 17.12 Mn -99.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 25,000.00
Mar 31, 2024 63,000.00
Dec 31, 2023 99,000.00
Sep 30, 2021 775,000.00
Jun 30, 2021 812,000.00
Mar 31, 2021 784,000.00
Dec 31, 2020 853,000.00
Sep 30, 2020 1.09 Mn
Jun 30, 2020 1.31 Mn
Mar 31, 2020 727,000.00
Dec 31, 2019 653,000.00
Sep 30, 2019 122,000.00
Jun 30, 2019 301,000.00
API Access

Yarrow Bioscience Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=YARW&period=max&api_key=YOUR_API_KEY